KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Equity (2016 - 2025)

TherapeuticsMD's Return on Equity history spans 14 years, with the latest figure at 0.0% for Q4 2025.

  • For Q4 2025, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Equity reached 0.0% in Q4 2025 per TXMD's latest filing, down from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 5.35% in Q2 2021 to a low of 16.9% in Q4 2022.
  • Average Return on Equity over 5 years is 0.18%, with a median of 0.01% recorded in 2024.
  • Peak YoY movement for Return on Equity: crashed -1795bps in 2022, then skyrocketed 1681bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 1.05% in 2021, then crashed by -1709bps to 16.9% in 2022, then surged by 99bps to 0.09% in 2023, then skyrocketed by 105bps to 0.0% in 2024, then crashed by -36bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for TXMD's Return on Equity are 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.0% (Q2 2025).